Skip to main
ALAB

ALAB Stock Forecast & Price Target

ALAB Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 41%
Buy 41%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Astera Labs Inc has demonstrated a strong financial performance, characterized by significantly higher revenue and an improved gross margin, which successfully offset increased operating expenses. The accelerating adoption of AI infrastructure has led to a surge in server shipments, contributing to better-than-expected growth for the company's product lines, particularly the PCIe Gen 6 offerings and Scorpio P designs. Looking ahead, the company has provided a robust revenue guidance of $249.0 million, reflecting an 8.0% quarter-over-quarter increase and a remarkable 76.5% year-over-year growth, positioning it as one of the fastest-growing entities within the semiconductor sector.

Bears say

Astera Labs Inc’s revenue growth is closely tied to the rate of infrastructure spending in data centers, making it vulnerable to potential downturns in capital investment due to macroeconomic conditions. In the last quarter, the company's non-GAAP operating expenses were reported at $70.7 million, which fell below expectations of $74.0 million, indicating cost challenges that may affect profitability. This reliance on external spending coupled with the shortfall in operational cost management contributes to a negative outlook on the company's stock performance.

ALAB has been analyzed by 17 analysts, with a consensus rating of Buy. 41% of analysts recommend a Strong Buy, 41% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Astera Labs Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Astera Labs Inc (ALAB) Forecast

Analysts have given ALAB a Buy based on their latest research and market trends.

According to 17 analysts, ALAB has a Buy consensus rating as of Dec 31, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $185.71, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $185.71, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Astera Labs Inc (ALAB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.